Online Only Articles

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia

EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology, Centre Hospitalier Universitaire (CHU), Nantes, France
Biology and Pathology Center, Hematology Laboratory, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
Hematology Laboratory, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), France
Biology and Pathology Center, Hematology Laboratory, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
Hematology, Centre Hospitalier Lyon Sud, Pierre Benite, France
Hematology, Hôpital Henri Mondor, AP-HP, Créteil, France
Hematology, Institut Gustave Roussy, Villejuif, France
EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology, Hôpital Saint-Louis, AP-HP, Paris, France
EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology Laboratory, Hôpital Saint-Louis, AP-HP, Paris, France
EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology, Hôpital Saint-Louis, AP-HP, Paris, France
Cytogenetic Laboratory, Hôpital de Versailles, Le Chesnay, France
Acute Leukemia French Association (ALFA) coordination, Hôpital Saint- Louis, AP-HP, Paris, France
Hematology, Hôpital de Versailles, Le Chesnay, France
Biology and Pathology Center, Hematology Laboratory, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology, Hôpital Avicenne, AP-HP, Bobigny, France
EA3518, Institut Universitaire d’Hématologie (IUH), University Paris Diderot, France;Hematology, Hôpital Saint-Louis, AP-HP, Paris, France
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.115576